+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Sample Preparation Market - Forecasts from 2024 to 2029

  • PDF Icon

    Report

  • 114 Pages
  • April 2024
  • Region: Global
  • Knowledge Sourcing Intelligence LLP
  • ID: 5978042
The sample preparation market was evaluated at US$6,820.288 million for the year 2022 and is projected to grow at a CAGR of 4.89%, reaching a market size of US$9,552.129 million by the year 2029.

A process for converting chemical and biological samples into a form that can be directly inserted into an instrument for analysis is termed sample preparation. The sample preparation market includes products that are used to prepare biological and chemical samples to analyze raw materials to detect undesirable elements. Sample preparation processes and products are widely used in the pharmaceutical sector, biotechnology, laboratories, food industry, and chemical industry. The growth and progress in the chemical and biological sectors are promoting the sample preparation market growth.

The importance and application of sample preparation in pharmaceutical research are one of the major factors giving potential to the global sample preparation market growth. Every research and analysis associated with the chemical and biological sector is supported by a proper sample preparation process and analysis. The large investments of major companies and governments in promoting the research and analysis sector of the chemical, biological, and food industries is boosting the market value of sample preparation products in the global market.

Miniaturization, automation, high-throughput performance, the potential of new sample preparation instruments to integrate with existing analytical instruments, and a reduction in solvent volume and time are also pushing the market value of sample preparation products in the global market. The efficiency showcased by sample analysis in giving accurate results in chemical and biological research is also fuelling the sample preparation market growth.

The competition of major market players for developing new technologies in the pharmaceutical and chemical field is also hiking the market value of sample preparation products, as they have a vital role in giving accurate results in research and experiments. The support offered by the government and funds offered by major players in the pharmaceutical field fuelled the research activities during the pandemic period, resulting in the sample preparation market growth.

Market Drivers:

The rising importance of sample preparation in pharmaceutical research poses to propel the market.

The vital role of the sample preparation process in pharmaceutical research is one of the major factors driving its market growth globally. Pharmaceutical analyses are performed utilizing various high-performance analytical instruments, even though most analytical devices cannot directly handle complex matrixes, necessitating a sample preparation step to extract and isolate the analytes of interest. The funding given for pharmaceutical and medical research by international companies and governmental organizations is boosting research activities, which also increases the market demand and value for sample preparation products.

According to a 2017 report by the Association of the British Pharmaceutical Industry, the global pharmaceutical industry has invested in research and development over the years, from USD 108.1 billion in 2006 to USD 156.7 billion in 2016. The increasing rate of research activities in the pharmaceutical field is also hiking the market value of the sample preparation market associated with it.

Increasing investments in the health and biological research sector are expected to surge the market.

The increasing investments in the health and biological research sector are hiking the market value of sample preparation products in the global market. The funding of 17.3 million USD by the German Research Foundation (DFG) in 2018 for German sequencing centers is one of the investments in the biological research sector.

The significant investments made by developing countries in the Asia Pacific and the Middle East region in the medical and healthcare research sector are also expected to push the market value of the sample preparation market in the forecasted years.

The North American region holds a major share of the market.

North America is estimated to hold a significant market share in the sample preparation market. As the United States is one of the major markets for biopharmaceuticals, the research, and developments taking place in the country contributed to the large market share of the North American region. North America is expected to hold a significant share of the sample preparation market due to its advanced healthcare infrastructure, high research and development activities, presence in the biotechnology and pharmaceutical industries, strict regulatory standards, increasing focus on diagnostic testing and personalized medicine, collaborations, biobanking initiatives, technological advancements, increased funding for life sciences research, and market competitiveness.

The region's advanced healthcare infrastructure, high research and development activities, presence of these industries, and strict regulatory standards contribute to the adoption of sophisticated sample preparation technologies. The growing focus on diagnostic testing and personalized medicine also drives the demand for accurate and efficient sample preparation methods. Collaborations between academic institutions, research centers, and industry players further foster the development of cutting-edge sample preparation technologies. The competitive landscape in the North American sample preparation market also stimulates market growth.

Key Developments:

  • January 2023-Scientists developed a new method to analyze the disruption caused by inhibiting the chaperone protein HSP90, a key strategy for cancer treatment. They used a multi-dimensional proteomic technique to gain a unique view of the effects of HSP90 inhibition, detecting changes in protein-protein associations and adding new proteins to the list. This understanding guides future efforts to develop next-generation HSP90 inhibitors for cancer treatment and advance our understanding of HSP90 inhibition's potential as a strategy for healthier aging. HSP90 is crucial for stabilizing or activating around 300 proteins in cells, many of which are oncogenic.
  • October 2022-Waters Corporation launched the Extraction+ connected device, a software-controlled product for the Waters™ Andrew+™ Pipetting Robot, which automates the preparation of biological, food, forensics, and environmental samples via solid phase extraction. This hands-free, automated approach saves scientists up to four hours of bench time for each sample set and reduces the risk of user-to-user variability. The device consists of a smart pump, a manifold for holding cartridges or elution plates, and software for creating and controlling pressure gradients during SPE cleanup procedures. The Extraction+ Connected Device is now available worldwide from Waters.
  • October 2022-nRichDX introduced two new products for liquid biopsy applications: the Revolution Circulating Free Total Nucleic Acid (cfTNA) Kit™ and the cfDNA Reference Standard products. These products are designed to aid researchers in developing liquid biopsy assays and are compatible with nRichDX's Revolution Sample Prep System™. The Revolution Sample Prep System is used for high-yield extraction of rare cfDNA from plasma or urine samples, which is the primary analyte used in liquid biopsy assays. The cfDNA Reference Standard, based on mono-nucleosomal DNA, contains tubes of thaw-and-use cfDNA extraction controls to measure the yield and efficiency of cfDNA extraction.

Segmentation:

By Product

  • Instruments
  • Sample Preparation Workstations/Systems
  • Liquid Handling Systems
  • Extraction Systems
  • Other Instruments
  • Consumables
  • Sample Preparation Kits
  • Other Products

By Application

  • Proteomics
  • Genomics
  • Epigenomics
  • Others

By End Users

  • Pharmaceuticals
  • Biotechnology
  • Laboratory Diagnostics
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • UK
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

Table of Contents

1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits to the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. SAMPLE PREPARATION MARKET BY PRODUCT
5.1. Introduction
5.2. Instruments
5.2.1. Market Opportunities and Trends
5.2.2. Growth Prospects
5.2.3. Geographic Lucrativeness
5.2.4. Sample Preparation Workstations/Systems
5.2.5. Liquid Handling Systems
5.2.6. Extraction Systems
5.2.7. Other Instruments
5.3. Consumables
5.3.1. Market Opportunities and Trends
5.3.2. Growth Prospects
5.3.3. Geographic Lucrativeness
5.4. Sample Preparation Kits
5.4.1. Market Opportunities and Trends
5.4.2. Growth Prospects
5.4.3. Geographic Lucrativeness
5.5. Other Products
5.5.1. Market Opportunities and Trends
5.5.2. Growth Prospects
5.5.3. Geographic Lucrativeness
6. SAMPLE PREPARATION MARKET BY APPLICATION
6.1. Introduction
6.2. Proteomics
6.2.1. Market Opportunities and Trends
6.2.2. Growth Prospects
6.2.3. Geographic Lucrativeness
6.3. Genomics
6.3.1. Market Opportunities and Trends
6.3.2. Growth Prospects
6.3.3. Geographic Lucrativeness
6.4. Epigenomics
6.4.1. Market Opportunities and Trends
6.4.2. Growth Prospects
6.4.3. Geographic Lucrativeness
6.5. Others
6.5.1. Market Opportunities and Trends
6.5.2. Growth Prospects
6.5.3. Geographic Lucrativeness
7. SAMPLE PREPARATION MARKET BY END USERS
7.1. Introduction
7.2. Pharmaceuticals
7.2.1. Market Opportunities and Trends
7.2.2. Growth Prospects
7.2.3. Geographic Lucrativeness
7.3. Biotechnology
7.3.1. Market Opportunities and Trends
7.3.2. Growth Prospects
7.3.3. Geographic Lucrativeness
7.4. Laboratory Diagnostics
7.4.1. Market Opportunities and Trends
7.4.2. Growth Prospects
7.4.3. Geographic Lucrativeness
7.5. Others
7.5.1. Market Opportunities and Trends
7.5.2. Growth Prospects
7.5.3. Geographic Lucrativeness
8. SAMPLE PREPARATION MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Product
8.2.2. By Application
8.2.3. By End Users
8.2.4. By Country
8.2.4.1. USA
8.2.4.1.1. Market Opportunities and Trends
8.2.4.1.2. Growth Prospects
8.2.4.2. Canada
8.2.4.2.1. Market Opportunities and Trends
8.2.4.2.2. Growth Prospects
8.2.4.3. Mexico
8.2.4.3.1. Market Opportunities and Trends
8.2.4.3.2. Growth Prospects
8.3. South America
8.3.1. By Product
8.3.2. By Application
8.3.3. By End Users
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.1.1. Market Opportunities and Trends
8.3.4.1.2. Growth Prospects
8.3.4.2. Argentina
8.3.4.2.1. Market Opportunities and Trends
8.3.4.2.2. Growth Prospects
8.3.4.3. Others
8.3.4.3.1. Market Opportunities and Trends
8.3.4.3.2. Growth Prospects
8.4. Europe
8.4.1. By Product
8.4.2. By Application
8.4.3. By End Users
8.4.4. By Country
8.4.4.1. Germany
8.4.4.1.1. Market Opportunities and Trends
8.4.4.1.2. Growth Prospects
8.4.4.2. France
8.4.4.2.1. Market Opportunities and Trends
8.4.4.2.2. Growth Prospects
8.4.4.3. UK
8.4.4.3.1. Market Opportunities and Trends
8.4.4.3.2. Growth Prospects
8.4.4.4. Others
8.4.4.4.1. Market Opportunities and Trends
8.4.4.4.2. Growth Prospects
8.5. Middle East and Africa
8.5.1. By Product
8.5.2. By Application
8.5.3. By End Users
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.1.1. Market Opportunities and Trends
8.5.4.1.2. Growth Prospects
8.5.4.2. UAE
8.5.4.2.1. Market Opportunities and Trends
8.5.4.2.2. Growth Prospects
8.5.4.3. Others
8.5.4.3.1. Market Opportunities and Trends
8.5.4.3.2. Growth Prospects
8.6. Asia Pacific
8.6.1. By Product
8.6.2. By Application
8.6.3. By End Users
8.6.4. By Country
8.6.4.1. China
8.6.4.1.1. Market Opportunities and Trends
8.6.4.1.2. Growth Prospects
8.6.4.2. India
8.6.4.2.1. Market Opportunities and Trends
8.6.4.2.2. Growth Prospects
8.6.4.3. Japan
8.6.4.3.1. Market Opportunities and Trends
8.6.4.3.2. Growth Prospects
8.6.4.4. South Korea
8.6.4.4.1. Market Opportunities and Trends
8.6.4.4.2. Growth Prospects
8.6.4.5. Taiwan
8.6.4.5.1. Market Opportunities and Trends
8.6.4.5.2. Growth Prospects
8.6.4.6. Thailand
8.6.4.6.1. Market Opportunities and Trends
8.6.4.6.2. Growth Prospects
8.6.4.7. Indonesia
8.6.4.7.1. Market Opportunities and Trends
8.6.4.7.2. Growth Prospects
8.6.4.8. Others
8.6.4.8.1. Market Opportunities and Trends
8.6.4.8.2. Growth Prospects
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Agilent Technologies Inc.
10.2. Bio-Rad Laboratories Inc.
10.3. Illumina
10.4. Merck Millipore (Merck KGaA)
10.5. Danaher Corporation
10.6. Roche
10.7. Perkinelmer, Inc.
10.8. Norgen Biotek Corporation
10.9. Qiagen N.V

Companies Mentioned

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Illumina
  • Merck Millipore (Merck KGaA)
  • Danaher Corporation
  • Roche
  • Perkinelmer, Inc.
  • Norgen Biotek Corporation
  • Qiagen N.V

Methodology

Loading
LOADING...

Table Information